Lack of efficacy of aurintricarboxylic acid and ethacrynic acid against vaccinia virus respiratory infections in mice

Antiviral Chemistry and Chemotherapy

Volumn 20, Issue 5, 2010, Pages 201-205

  Smee, Donald F ^a   Hurst, Brett L ^a   Wong, Min Hui ^a  

^a UTAH STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AURINTRICARBOXYLIC ACID; CIDOFOVIR; ETACRYNIC ACID; PLACEBO;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; COWPOX; DISEASE EXACERBATION; DRUG EFFICACY; DRUG POTENCY; DRUG SELECTIVITY; DRUG TREATMENT FAILURE; EXPERIMENTAL INFECTION; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; TREATMENT DURATION; VACCINIA VIRUS; VIRAL RESPIRATORY TRACT INFECTION; VIRUS CULTURE; VIRUS INHIBITION; VIRUS PLAQUE; VIRUS VIRULENCE;

EID: 77951187151     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.3851/imp1480     Document Type: Article

References (18)

1. Myskiw C, Deschambault Y, Jefferies K, et al. Aurintricarboxylic acid inhibits the early stage of vaccinia virus replication by targeting both cellular and viral factors. J Virol 2007; 81:3027-3032. (Pubitemid 46447068)
2. Spisakova M, Cizek Z, Melkova Z. Ethacrynic and alpha-lipoic acids inhibit vaccinia virus late gene expression. Antiviral Res 2009; 81:156-165.
3. Magee WC, Aldern KA, Hostetler KY, et al. Cidofovir and (S)-9-[3-hydroxy-(2-phosphonomethoxy)propyl]adenine are highly effective inhibitors of vaccinia virus DNA polymerase when incorporated into the template strand. Antimicrob Agents Chemother 2008; 52:586-597
4. Yang G, Pevear DC, Davies MH, et al. An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus challenge. J Virol 2005; 79:13139-13149. (Pubitemid 41433232)
5. Leggiadro RJ. Bioterrorism: a clinical reality. Pediatr Ann 2007; 36:352-358.
6. Strikas RA, Neff LJ, Rotz L, et al. US civilian smallpox preparedness and response program, 2003. Clin Infect Dis 2008; 46 Suppl 3:S157-S167. (Pubitemid 351590127)
7. Smee DF, Sidwell RW. A review of compounds exhibiting anti-orthopoxvirus activity in animal models. Antiviral Res 2003; 57:41-52.
8. Smee DF. Progress in the discovery of compounds inhibiting orthopoxviruses in animal models. Antivir Chem Chemother 2008; 19:115-124.
9. Smee DF, Wandersee MK, Bailey KW, et al. Cell line dependency for antiviral activity and in vivo efficacy of N-methanocarbathymidine against orthopoxvirus infections in mice. Antiviral Res 2007; 73:69-77.
10. Smee DF, Humphreys DE, Hurst BL, et al. Antiviral activities and phosphorylation of 5-halo-2′-deoxyuridines and N-methanocarbathymidine in cells infected with vaccinia virus. Antivir Chem Chemother 2008; 19:15-24.
11. Smee DF, Morrison AC, Barnard DL, et al. Comparison of colorimetric, fluorometric, and visual methods for determining anti-influenza (H1N1 and H3N2) virus activities and toxicities of compounds. J Virol Methods 2002; 106:71-79.
12. Smee DF, Wong MH, Bailey KW, et al. Effects of four antiviral substances on lethal vaccinia virus (IHD strain) respiratory infections in mice. Int J Antimicrob Agents 2004; 23:430-437.
13. Milani M, Mastrangelo E, Bollati M, et al. Flaviviral methyltransferase/RNA interaction: structural basis for enzyme inhibition. Antiviral Res 2009; 83:28-34.
14. Chen Y, Bopda-Waffo A, Basu A, et al. Characterization of aurintricarboxylic acid as a highly potent hepatitis C virus replicase inhibitor. Antivir Chem Chemother 2009; 20:19-36.
15. Balzarini J, Mitsuya H, De Clercq E, et al. Aurintricarboxylic acid and Evans Blue represent two different classes of anionic compounds which selectively inhibit the cytopathogenicity of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus. Biochem Biophys Res Commun 1986; 136:64-71. (Pubitemid 16046696)
16. Hung HC, Tseng CP, Yang JM, et al. Aurintricarboxylic acid inhibits influenza virus neuraminidase. Antiviral Res 2009; 81:123-131.
17. He R, Adonov A, Traykova-Adonova M, et al. Potent and selective inhibition of SARS coronavirus replication by aurintricarboxylic acid. Biochem Biophys Res Commun 2004; 320:1199-1203 (Pubitemid 38916671)
18. Hunt DM, Wagner RR. Inhibition by aurintricarboxylic acid and polyethylene sulfonate of RNA transcription of vesicular stomatitis virus. J Virol 1975; 16:1146-1153.